HUBEI SOUNDNY BIOTECHNOLOGY

Established in 2009, Hubei Shengqi'an Biotechnology Co., Ltd. is a new biotechnology enterprise specializing in the research, development, application and promotion of drug-loaded vesicle treatment for cancer technology in China. It was officially listed in February 2017. The stock code: 870592. Sheng Qi'an Bio focuses on the field of cancer treatment, and has established products and research and development pipelines covering solid tumors and complications such as cholangiocarcinoma, lung canc... er, malignant pleural effusion and malignant ascites. Up to now, drug-loaded vesicle treatment of tumor technology has been approved for marketing in Anhui, Shenzhen, Hubei and Tianjin provinces, and the first in the Department of Respiratory Medicine of the Second Affiliated Hospital of Anhui Medical University to carry out clinical application for the benefit of cancer patients. Based on the independent research and development of drug-loaded vesicles for the treatment of oncology technology, Sheng Qi'an Biotechnology has established a global patent system (Chinese Patent No.: ZL 201110241369.8) to establish the world's first drug-loaded vesicle treatment tumor technology.More